Biopharmaceuticals Market Reports

Find the information you need on the biopharmaceutical industry. The Kalorama Information collection of market research reports provides insights into product and market trends, analyses, opportunities, projections, sales, and marketing strategies. Specifics on market share, segmentation, size, and growth of the US and global biopharmaceutical markets are also featured. You’ll find the latest information on protein therapeutics, generic biologics, and growth factor inhibitors.

Title	Published	Price
Biogenerics: The World Market for Biosimilars In one sense, the opportunity for follow-on proteins is as good as ever. Some of the biggest-selling biologics developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, have lost patent protection or are set to lose patent protection  |  more... Search inside this report	Apr 1, 2008	$3,500.00
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells. For market-watchers in the pharmaceutical industry, the  |  more...	Mar 1, 2008	$3,995.00
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market Cancer is the second most common cause of death in the industrialized world. At this time, treatment for cancer focuses on some combination of surgery, radiation, and chemotherapy. But over the next five years, treatment is going to dramatically change. as detailed in the report Monoclonal Antibodies, Vaccines and  |  more...	May 1, 2007	$1,995.00
Drug Delivery Markets, Vol I: Oral Delivery The oral drug delivery market is the largest segment of the drug delivery market, and there’s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, and seeking to tap into the growing elderly  |  more... Buy by the section | Search inside this report	Jan 1, 2007	$2,495.00
Cell Culture: The World Market for Media, Sera, and Reagents As the biopharmaceutical market grows, so will the cell culture products market. Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells for  |  more... Buy by the section | Search inside this report	Jan 1, 2007	$3,900.00
Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 2nd Edition This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector. The report contains vital market statistics on three main segments of pharmaceutical contract  |  more... Buy by the section | Search inside this report	Sep 1, 2006	$3,900.00
The Protein Therapeutics Market: The Science and Business of a Growing Sector The protein therapeutics sector is a story of triumphant science, representing both life-saving treatments for millions and a multi-billion dollar industry. This report details both the scientific and business aspects of the protein therapeutics marketplace, including market size and growth, competitive market share, geographical segmentation, top products, and forecasts to  |  more... Buy by the section | Search inside this report	Jun 1, 2006	$3,900.00
Transgenic Animals and Plants in Pharmaceutical Research and Manufacturing With the mapping of the human genome and the concomitant explosion of proteomics, a steady stream of biopharmaceuticals have been launched—recombinant therapeutic proteins, monoclonal antibody-based products used for therapeutic or in vivo diagnostic purposes, and nucleic acid-based products. As the rate of regulatory approval for biopharmaceuticals increases, the  |  more... Buy by the section | Search inside this report	Jan 1, 2006	$2,995.00
The Market for Generic Biologics: Issues, Trends, and Market Potential, 2nd edition Some of the biggest-selling biological drugs developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, are set to lose patent protection in the United States in 2005 and soon after. This opens up a market currently worth over $30 billion  |  more... Buy by the section | Search inside this report	Nov 1, 2005	$2,500.00
The Market for Generic Biologics: Issues, Trends, and Market Potential Biologics, or biopharmaceuticals, are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However, biogenerics are not generic biologics, because there can technically be  |  more... Buy by the section | Search inside this report	Jun 1, 2004	$1,500.00
Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or blocks the ability of cells to divide and multiply. Blood and tissue growth factors have become exciting targets for compounds  |  more... Buy by the section | Search inside this report	Mar 1, 2004	$3,500.00
Growth Factors: Indications, Products, and Markets Growth factors are gene products that play important roles in the regulation of cell division and tissue proliferation. Generally, the binding of a growth factor to its receptor initiates or, in some cases, blocks the ability of cells to divide and multiply. The nature and mode of action of these  |  more... Buy by the section | Search inside this report	Oct 1, 2003	$2,625.00
Opportunities in Stem Cell Technology In the nascent, but rapidly growing field of stem cell therapies, products are a long way from being commercialized. However, the market potential for stem cell therapies products is very large. This report aims to identify those technologies and opportunities in the United States with the greatest future opportunities, the  |  more... Buy by the section | Search inside this report	Feb 1, 2002	$2,625.00
Title	Published	Price